Search

Your search keyword '"Beesley, Jonathan"' showing total 721 results

Search Constraints

Start Over You searched for: Author "Beesley, Jonathan" Remove constraint Author: "Beesley, Jonathan"
721 results on '"Beesley, Jonathan"'

Search Results

101. Supplementary Figure 1 from Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer

102. Supplementary Methods, Tables 1-3, Figure 1 from Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

103. Supplementary Table 1 from Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer

104. Supplementary Tables 1-4 from Tagging Single Nucleotide Polymorphisms in Cell Cycle Control Genes and Susceptibility to Invasive Epithelial Ovarian Cancer

105. Supplementary Table 2 from Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer

106. Supplementary Table 4 from Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer

107. Supplementary Tables 1-13 from 19p13.1 Is a Triple-Negative–Specific Breast Cancer Susceptibility Locus

108. Additional file 1 of CRISPR screens identify gene targets at breast cancer risk loci

109. Additional file 9 of CRISPR screens identify gene targets at breast cancer risk loci

110. RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors

111. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

112. Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways

113. The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

115. Genome-wide association study for ovarian cancer susceptibility using pooled DNA

116. CRISPR screens identify gene targets and drug repositioning opportunities at breast cancer risk loci

117. Polymorphisms in the FGF2 Gene and Risk of Serous Ovarian Cancer: Results From the Ovarian Cancer Association Consortium

118. Identification of Novel Genetic Markers of Breast Cancer Survival

119. CRISPR screens identify gene targets and drug repositioning opportunities at breast cancer risk loci

120. Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals

121. Consequences of Germline Variation Disrupting the Constitutional Translational Initiation Codon Start Sites of MLH1 and BRCA2: Use of Potential Alternative Start Sites and Implications for Predicting Variant Pathogenicity

122. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

124. Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development

125. DNA mismatch repair gene MSH6 implicated in determining age at natural menopause

126. No evidence that GATA3 rs570613 SNP modifies breast cancer risk

131. Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer.

132. Epigenome erosion drives neural crest-like phenotypic mimicry in triple-negative breast cancer and other SOX10+ malignancies

133. Genome-wide association study identifies novel breast cancer susceptibility loci

134. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

135. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

136. Additional file 8 of Exploring the link between MORF4L1 and risk of breast cancer

137. Additional file 7 of Exploring the link between MORF4L1 and risk of breast cancer

138. Additional file 16 of Exploring the link between MORF4L1 and risk of breast cancer

139. Additional file 5 of Exploring the link between MORF4L1 and risk of breast cancer

140. Additional file 9 of Exploring the link between MORF4L1 and risk of breast cancer

141. MOESM3 of Non-coding RNAs underlie genetic predisposition to breast cancer

142. Additional file of Exploring the link between MORF4L1 and risk of breast cancer

143. Identification of a genetic variant associated with treatment outcome in ovarian cancer: the potential role of cholesterol metabolism as a determinant of response to chemotherapy

144. Functional polymorphisms in the TERT promoter are associated with risk of serious ovarian and breast cancer

145. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

146. eQTL Colocalization Analyses Identify NTN4 as a Candidate Breast Cancer Risk Gene

147. 11q13 Is a Susceptibility Locus for Hormone Receptor Positive Breast Cancer

149. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium†

150. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

Catalog

Books, media, physical & digital resources